换一批
换一批Rising serum potassium and creatinine concentrations after prescribing renin-angiotensin-aldosterone system blockade:how much should we worry?
摘要Renin-angiotensin-aldosterone system (RAAS) blockade is often the first-line medication for treating pediatric and adult patients with hypertension,especially those with pre-existing chronic kidney disease (CKD) [1,2].However,the rise in serum creatinine and potassium concentrations following RAAS blocked may pose therapeutic challenges whether it is safe to treat hypertensive patients with CKD,by inhibiting [3].Thus,many clinicians neglect to use angi-otensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blockade (ARB) especially in patients with CKD because of fear in either reduction of glomerular filtration rate (GFR) or elevation in serum creatinine and potassium concentrations.
更多相关知识
- 浏览4
- 被引0
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
